XNAS:F:F-Xtrackers NASDAQ 100 UCITS ETF 1C EUR (EUR)

ETF | Others |

Last Closing

USD 43.495

Change

+0.49 (+1.14)%

Market Cap

N/A

Volume

151.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.74%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.34 (+0.97%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.32 (+0.56%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.10 (+0.68%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.55 (+0.68%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.22%)

USD 51.63B
0ZC:F Zscaler Inc

-0.95 (-0.43%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.46 (+0.36%)

USD 24.77B

ETFs Containing XNAS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.93% 20% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.93% 21% F 38% F
Trailing 12 Months  
Capital Gain 9.96% 79% B- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.96% 76% C+ 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 18.49% 93% A 80% B-
Dividend Return 18.49% 91% A- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.97% 29% F 76% C+
Risk Adjusted Return 108.99% 96% N/A 95% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.